Clinical Trial Update: Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated colony-stimulating factors as treatment for children with recurrent or refractory solid tumors. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Children's Oncology Group | Conditions: Cancer | Phase 1 | Status: COMPLETED